Merck & Company Inc (MRK)vsNortech Systems Incorporated (NSYS)
MRK
Merck & Company Inc
$120.79
-3.46%
HEALTHCARE · Cap: $285.64B
NSYS
Nortech Systems Incorporated
$16.68
+0.79%
HEALTHCARE · Cap: $47.42M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 53903% more annual revenue ($65.77B vs $121.79M). MRK leads profitability with a 13.6% profit margin vs 0.8%. MRK trades at a lower P/E of 32.6x. MRK earns a higher WallStSmart Score of 50/100 (D+).
MRK
Hold50
out of 100
Grade: D+
NSYS
Hold46
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-49.3%
Fair Value
$80.88
Current Price
$120.79
$39.91 premium
Intrinsic value data unavailable for NSYS.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Strong operational efficiency at 38.6%
Generating 2.9B in free cash flow
Reasonable price relative to book value
Earnings expanding 125.7% YoY
Safe zone — low bankruptcy risk
Areas to Watch
Premium valuation, high expectations priced in
4.9% revenue growth
Elevated debt levels
Weak financial health signals
Smaller company, higher risk/reward
ROE of 3.0% — below average capital efficiency
0.8% margin — thin
Operating margin of 0.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : NSYS
The strongest argument for NSYS centers on Price/Book, EPS Growth, Altman Z-Score. Revenue growth of 12.7% demonstrates continued momentum.
Bear Case : MRK
The primary concerns for MRK are P/E Ratio, Revenue Growth, Debt/Equity.
Bear Case : NSYS
The primary concerns for NSYS are Market Cap, Return on Equity, Profit Margin. A P/E of 44.7x leaves little room for execution misses. Thin 0.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
MRK carries more volatility with a beta of 0.20 — expect wider price swings.
NSYS is growing revenue faster at 12.7% — sustainability is the question.
MRK generates stronger free cash flow (2.9B), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - GENERAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MRK scores higher overall (50/100 vs 46/100). Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Nortech Systems Incorporated
HEALTHCARE · MEDICAL DEVICES · USA
Nortech Systems Incorporated is an electronic manufacturing services company in the United States, Mexico, and China. The company is headquartered in Maple Grove, Minnesota.
Visit Website →Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?